Titel	Veröffentlichungsdatum	Sprache	Zitate
New Drug Innovation and Pharmaceutical Industry Structure: Trends in the Output of Pharmaceutical Firms	2000/10/01	English	34
Trends in Drug Development Costs, Times, and Risks	1995/04/01	English	33
Analysis of Data with Imbalance in the Baseline Outcome Variable for Randomized Clinical Trials	2001/10/01	English	32
The Legal and Regulatory Framework of Herbal Medicinal Products in the European Union: A Focus on the Traditional Herbal Medicines Category	2011/01/01	English	32
Summarizing Laboratory Data with Different Reference Ranges in Multi-Center Clinical Trials	1992/01/01	English	32
Quantum of Effectiveness Evidence in FDA’s Approval of Orphan Drugs	2012/03/01	English	32
Impact of Unrecognized Dosing Errors on the Cost and Effectiveness of Pharmaceuticals	1988/07/01	English	32
Confidentiality and Trial Integrity Issues for Adaptive Designs	2006/10/01	English	31
The New Drug Approvals of 1996, 1997, and 1998: Drug Development Trends in the User Fee Era	2000/01/01	English	31
Cross-Cultural Comparability of Quality of Life Measures	1993/04/01	English	31
The Significance of Quality for Efficacy and Safety of Herbal Medicinal Products	2000/01/01	English	31
Adjustment of Treatment Effect for Covariates in Clinical Trials: Statistical and Regulatory Issues	2000/04/01	English	31
The Use of the World Health Organisation Anatomical Therapeutic Chemical/Defined Daily Dose Methodology in Canada	2004/01/01	English	31
Modeling and Interpreting QTc Prolongation in Clinical Pharmacology Studies	2005/10/01	English	30
One Large, Well-Designed, Multicenter Study as an Alternative to the Usual Fda Paradigm	1999/01/01	English	29
In Vitro/In Vivo Correlations	1995/07/01	English	29
Population Pharmacokinetics and Pharmacodynamics: An Underutilized Resource	1998/07/01	English	29
Factors Affecting Physician Reporting of Adverse Drug Reactions	1986/04/01	English	29
A Statistical Framework for Decision Making in Confirmatory Multipopulation Tailoring Clinical Trials	2012/11/01	English	28
Evaluation of Data Entry Errors and Data Changes to an Electronic Data Capture Clinical Trial Database	2011/07/01	English	28
A Development and Validation Process for a Disease-Specific Quality of Life Instrument	1996/01/01	English	28
Management of Pharmacokinetic Data Using HP-3357/Mainframe Ibm Interfacing	1987/04/01	English	28
Statistical Analyses of Adverse Event Data from Clinical Trials	1987/01/01	English	28
A Fully Bayesian Approach to Calculating Sample Sizes for Clinical Trials with Binary Responses	2002/01/01	English	27
Statistical Evaluation of Similarity Factor f2 as a Criterion for Assessment of Similarity Between Dissolution Profiles	1997/10/01	English	27
Issues in Adjusting for Covariates Arising Postrandomization in Clinical Trials	1999/10/01	English	27
Risk-Based Source Data Verification Approaches: Pros and Cons	2010/11/01	English	26
Choice of Delta in Equivalence Testing	2001/10/01	English	26
Electrocardiogram Reference Ranges Derived from a Standardized Clinical Trial Population	2005/10/01	English	26
Testing in a Prespecified Subgroup and the Intent-to-Treat Population	2012/03/01	English	26